Roquette America
- Company typePrivate
- Founded1933
- HeadquartersGurnee, United States
- Headcount10,001+
- GTM typeB2B
- OfferingHardware or Manufacturing
What Roquette America does
Roquette America is the US subsidiary of Roquette Frères, a French family-owned global leader in plant-based ingredients founded in 1933 and headquartered in Lestrem, France. The company operates a proprietary biorefinery model that processes over 6 million tons annually of renewable agricultural raw materials (corn, wheat, potato, pea, fava bean, seaweed, cellulose) into more than 700 ingredients, including plant proteins (NUTRALYS), soluble fibers (NUTRIOSE), specialty starches (CLEARAM), polyols (SWEETPEARL), maltodextrins (GLUCIDEX), pharmaceutical excipients, and bio-based chemicals (BIOSUCCINIUM). It serves 5,000+ customers across six segments — Food & Nutrition, Health & Pharma, Cosmetics, Animal Nutrition, Bioindustry, and Agriscience — through 40+ manufacturing sites and 20+ R&D centers in 150+ countries.
The business model is enterprise B2B with direct sales, quote-based pricing, and deep Customer Technical Services (CTS) integration. Approximately 1 in 2 oral dosage forms globally contain Roquette excipients and 45 billion modified-release tablets annually include its products, illustrating deep embedded positioning in regulated pharma supply chains. The FY2025 acquisition of IFF Pharma Solutions for up to $2.85 billion — financed in part by an inaugural €1.2 billion bond — transformed Roquette into a top-tier pharmaceutical excipients and consumer healthcare supplier, adding capsule technologies (Qualicaps, SeaGel, LYCAGEL Flex, VERDIGEL) and drug delivery systems. FY2025 consolidated turnover was €4.9 billion with EBITDA of €612 million (12.6% margin), supported by 11,000+ employees worldwide. The company remains family-controlled under Chairman Edouard Roquette, with Thierry Fournier as CEO, and operates without external private equity or venture capital backing.
Roquette America firmographics
Firmographics- Name
- Roquette America
- Legal name
- Roquette Frères
- Website
- https://roquette.com
- Company type
- Private
- Founded year
- 1933
- Operating status
- Operating
- Headcount range
- 10,001+ employees
- Ownership category
- akta.pro rank
Roquette America industry classification
Industry- Product category
- Plant-based ingredients for food and pharmaceutical applications
- NAICS
- Starch and Vegetable Fats and Oils Manufacturing (31122), Food Manufacturing (311), Grain and Oilseed Milling (3112)
- SIC
- Food And Kindred Products (2000), Grain Mill Products (2040), Industrial Organic Chemicals (2860)
- akta.pro industry
- Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B)Agriculture & Food Production/Dairy Processing/Dairy Alternatives Processing (Plant-Based “Milk”, Yogurt & Cheese Analogues)Biological Formulation, Fermentation & Scale-Up ManufacturingAgriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
Keywords
Where Roquette America is headquartered
LocationHeadquarters
- HQ city
- Gurnee
- HQ country
- United States
- HQ region
- North America
Offices17 records
Markets served
Roquette America business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Plant-Based Ingredients B2B Sales: Roquette generates revenue through direct B2B sales of plant-based ingredients and pharmaceutical excipients to food manufacturers, pharmaceutical companies, cosmetics brands, and industrial customers worldwide. Revenue stream includes proteins, fibers, starches, polyols, maltodextrins, and specialty ingredients sold under brand names including NUTRALYS, NUTRIOSE, CLEARAM, METHOCEL, SWEETPEARL, and GLUCIDEX.
- Pharmaceutical Excipients and Solutions: Revenue from pharmaceutical excipients, capsules, and drug delivery solutions. Includes hard capsules (Qualicaps), coating systems, and functional excipients for oral dosage, biologics, and consumer healthcare products. Expanded significantly through 2025 acquisition of IFF Pharma Solutions.
- Specialty Ingredients: Specialty ingredients for bioindustry applications including fermentation carbon sources, BIOSUCCINIUM bio-succinic acid, POLYSORB isosorbide, alginates, and cellulosics for industrial customers in paper, packaging, construction, home care, and biofuel sectors.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Roquette America product offering
Product offeringCore offering
Roquette America manufactures and sells plant-based ingredients for food, pharmaceutical, cosmetic, and industrial applications, processing renewable agricultural raw materials (corn, wheat, potato, pea) through a proprietary biorefinery model. The company produces over 700 ingredients including plant proteins, fibers, starches, polyols, maltodextrins, pharmaceutical excipients, capsules, and bio-based chemicals sold under brands such as NUTRALYS, NUTRIOSE, CLEARAM, SWEETPEARL, GLUCIDEX, METHOCEL, and BIOSUCCINIUM.
Product overview
Roquette America offers a comprehensive portfolio of plant-based ingredients and pharmaceutical solutions across multiple business units. The core Food & Nutrition segment includes NUTRALYS® plant proteins (pea and fava protein isolates and textured proteins), NUTRIOSE® soluble fibers, CLEARAM® specialty starches, METHOCEL™ cellulosics, SWEETPEARL® polyols, and GLUCIDEX® maltodextrins. The Health & Pharma Solutions segment provides pharmaceutical excipients, capsules (through Qualicaps), and advanced drug delivery systems. Consumer Healthcare offerings include SeaGel® carrageenan softgels, LYCAGEL® Flex, and VERDIGEL™ pectin solutions. The Bioindustry segment features BIOSUCCINIUM® bio-succinic acid, POLYSORB® isosorbide, SOLULYS® fermentation proteins, and alginate products. Roquette Beauté serves the cosmetics market with alginate-based ingredients and innovative capsule technologies like DS 700. The portfolio also includes the HORIZONS AI-powered foresight platform. Recent strategic acquisitions including IFF Pharma Solutions and Qualicaps have expanded capabilities in pharmaceutical excipients and capsule technologies.
Differentiator
Problem solved
Functional benefit
Brands
- Roquette Beauté: Cosmetics ingredient brand delivering high-performance, sustainable ingredients for cosmetic products
- NUTRALYS®
- NUTRIOSE®
- CLEARAM®
- SWEETPEARL®
- GLUCIDEX®
- BIOSUCCINIUM®
- Qualicaps
- SeaGel®
- VERDIGEL™
- AMYSTA™
Products and services
- NUTRALYS Plant Proteins Pea and fava bean protein isolates and textured proteins for food and nutrition applications including plant-based meat alternatives, dairy alternatives, sports nutrition, and beverages.
- NUTRIOSE Soluble Fibers Soluble fiber ingredients for fiber enrichment in food and beverage applications, supporting gut health and digestive wellness.
- CLEARAM and Specialty Starches Starch-based ingredients including tapioca, corn, and other botanical starches for texturizing, thickening, and binding in food applications.
- METHOCEL and Cellulosics Cellulose derivatives and methylcellulose products for texturizing, film-forming, and functional properties in food, pharmaceutical, and industrial applications.
- SWEETPEARL and Polyols Sugar alcohols including sorbitol, maltitol, and xylitol for sugar reduction, confectionery, and oral care applications.
- GLUCIDEX Maltodextrins Maltodextrins and dried glucose syrup as carbohydrates for food processing, fermentation carbon sources, and functional ingredients.
- Pharmaceutical Excipients Functional excipients for oral dosage forms including binding agents, disintegrants, fillers, and coating systems for pharmaceutical formulations. Portfolio expanded through IFF Pharma Solutions acquisition.
- Qualicaps Capsules Hard capsule technologies including HPMC and gelatin capsules for pharmaceutical and nutraceutical applications, acquired through 2023 Qualicaps acquisition.
- Biologics Excipients Functional excipients supporting protein stabilization, viscosity reduction, and bioprocessing efficiency in biologic drug development.
- Advanced Drug Delivery Systems Controlled and targeted release technologies with multifunctional excipients and advanced formulation solutions for enhanced bioavailability and patient compliance.
- Coating Systems
- BIOSUCCINIUM Bio-succinic Acid Plant-based succinic acid for improving environmental footprint in packaging, coatings, and high-quality chemical intermediates for biobased materials.
- POLYSORB Isosorbide Versatile monomer optimizing heat and surface resistance, optical properties, recyclability, carbon footprint, and polymer safety for performance materials.
- STABILYS BA 25 Modified starch designed to deliver high-performance grease resistance for paper and board packaging, enabling removal of fluoropolymers.
- SeaGel Softgel Technology Carrageenan-based softgel technology for dietary supplements and OTC products, providing consumer-friendly delivery solutions.
- LYCAGEL Flex Softgel Technology Softgel technology for consumer healthcare and nutraceutical applications, expanded through recent acquisitions.
- VERDIGEL Pectin Solutions Pectin-based solutions for gummy formulations in dietary supplements and OTC products, supporting clean-label and plant-based positioning.
- Beauté by Roquette AG Series Alginate-based technologies for cosmetics including AG 215, AG 219, and AG 291, offering enhanced rheology and viscosity for skin care, hair care, and color cosmetics.
- Beauté by Roquette DS 700 Water-resistant capsule with nearly 100% resistance designed for long-lasting beauty applications in personal care.
- QUALIS-Pro UV Laser Tablet Printing System Next-generation UV laser tablet printing and inspection system integrating advanced printing and inspection technology for pharmaceutical manufacturing.
- AMYSTA L 123 Thermally Soluble Pea Starch Label-friendly thermally soluble pea starch designed as a label-friendly solution for food manufacturers.
Quantifiable outcome
- ~1 out of 2 oral dosage forms contain two or more Roquette excipients
- +5 more outcomes
Companies that use Roquette America
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles4 records
Roquette America technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Roquette America partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Beyond MeatcoreMulti-year supply agreement for pea protein covering 2026 and 2027 to secure Beyond Meat's supply chain amid challenging plant-based market conditions. Roquette supplies Nutralys pea protein isolates for plant-based meat alternative products.
- BonumosecoreStrategic collaboration to enhance production of tagatose, a natural sweetener with health benefits. Partnership focuses on technological and scale-up development to meet growing demand for healthier sugar alternatives in food formulations.
- IFF (International Flavors & Fragrances)coreRoquette acquired IFF Pharma Solutions business for up to $2.85 billion in 2025, strengthening pharmaceutical offerings. The acquisition included excipients for oral dosage solutions and expanded Roquette's capsule portfolio through Qualicaps acquisition.
- Plant-Based Foods of CanadaminorIndustry collaboration through annual conference to advance plant-based protein sector in Canada, discussing supply chain sustainability, grower relationships, and market challenges.
- ADMminorKey competitor in plant-based protein market. Both companies investing in alternative protein technologies and capacity expansion.
- Louis Dreyfus Company (LDC)minorPartnership between LDC and Seven Oaks Hospital to develop new pea protein ingredients focusing on health benefits for older adults. LDC opened $500 million pea protein isolate plant in Canada in February 2024.
Scale indicators13 records
Recent moves16 records
Expansion highlights6 records
Roquette America competitors and assessment
Company assessmentDirect peers
- Ingredion: Ingredion is a leading global ingredient solutions provider specializing in starches, sweeteners, and plant-based proteins derived from corn, tapioca, and other crops. Direct competitor to Roquette across food ingredients, polyols, and specialty starches with comparable B2B enterprise sales model.
- ADM (Archer Daniels Midland): ADM is a global leader in plant-based proteins, particularly pea and soy protein isolates used in meat alternatives, with significant investment in alternative protein capacity. Direct competitor to Roquette in food, plant-based nutrition, and bioindustry ingredients.
- Tate & Lyle: Tate & Lyle is a specialty food ingredients company focused on sweeteners, texturants, and fibers including soluble corn fiber and polyols. Direct competitor to Roquette in food ingredients, sugar reduction, and specialty starch applications.
- Kerry Group: Kerry Group is a global B2B ingredient supplier focused on taste and nutrition systems, including plant-based proteins, fibers, and functional ingredients for food manufacturers. Direct competitor to Roquette in food and nutrition, with comparable customer base among food and beverage manufacturers.
- DSM-Firmenich: DSM-Firmenich is a global nutrition, health, and beauty ingredients company with overlapping capabilities in plant-based proteins, vitamins, and pharmaceutical excipients. Direct competitor in nutrition, personal care, and pharma excipients with comparable R&D and B2B go-to-market model.
- Glanbia: Glanbia is a global nutrition company specializing in dairy and plant-based protein ingredients, including pea protein for food and beverage applications. Direct competitor in plant-based protein and nutrition markets with comparable ingredient portfolio to Roquette's NUTRALYS line.
- Corbion: Corbion is a Dutch biobased ingredients company producing lactic acid, alginates, and biobased chemicals from renewable feedstocks. Direct peer in bioindustry and bio-based chemicals with comparable renewable-feedstock biorefinery model to Roquette's BIOSUCCINIUM and POLYSORB products.
- Lonza: Lonza is a global contract manufacturing and ingredients company serving pharmaceutical, nutrition, and personal care customers, with significant excipient and cellulosics production. Direct competitor in pharmaceutical excipients following Roquette's acquisition of IFF Pharma Solutions, with comparable pharma CDMO-adjacent capabilities.
Broad incumbents
- Cargill: Cargill is one of the world's largest agricultural commodity processors with extensive plant-based protein, starch, and bioindustrial ingredient operations. Broad incumbent across food, animal nutrition, and bioindustry with overlapping capabilities to Roquette but operating at much larger and more diversified scale.
Regional players
- Südzucker: Südzucker is Europe's largest sugar producer with a substantial starch/fruit ingredients division (Agrana) producing starches, polyols, and bioethanol from corn, wheat, and potato. Direct peer in starch and polyol manufacturing with strong European regional overlap to Roquette's core markets.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Roquette America social profiles
Digital presenceRoquette America compliance and trust
Trust signalCompliance16 records
Roquette America financial estimates
Financial estimateRevenue estimate
Valuation estimate
Roquette America leadership team
Management profileNumber of profiles
Profiles12 records
Roquette America subsidiaries and ownership
Company hierarchySubsidiaries7 records
Roquette America funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Roquette America M&A and investment
M&A and investmentM&A2 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Roquette America
What does Roquette America do?
Roquette America manufactures and sells plant-based ingredients for food, pharmaceutical, cosmetic, and industrial applications, processing renewable agricultural raw materials (corn, wheat, potato, pea) through a proprietary biorefinery model. The company produces over 700 ingredients including plant proteins, fibers, starches, polyols, maltodextrins, pharmaceutical excipients, capsules, and bio-based chemicals sold under brands such as NUTRALYS, NUTRIOSE, CLEARAM, SWEETPEARL, GLUCIDEX, METHOCEL, and BIOSUCCINIUM.
Is Roquette America a public or private company?
Roquette America is a private company. It is classified as family owned and is currently operating.
When was Roquette America founded?
Roquette America was founded in 1933. It employs 10,001+ people.
Where is Roquette America based?
Roquette America is headquartered in Gurnee, United States, in the North America region.
How does Roquette America make money?
Three revenue lines are on record. Plant-Based Ingredients B2B Sales are the primary driver. The others are pharmaceutical Excipients and Solutions and specialty Ingredients.
Who are Roquette America's main competitors?
Direct peers on record are Ingredion, ADM (Archer Daniels Midland), Tate & Lyle, Kerry Group, DSM-Firmenich, Glanbia, Corbion and Lonza. Cargill is listed as a broad incumbent. Südzucker is listed as a regional player.
Does Roquette America have an API?
No public API is recorded for Roquette America.
What industry is Roquette America in?
Roquette America's product category is Plant-based ingredients for food and pharmaceutical applications. Its primary akta.pro industry code is AFAHAJAI, Plant-Based Dairy-Alternative Ingredients & Bases Manufacturing (Emulsions, Fat Systems, Protein/Starch Bases for B2B), with a secondary code of AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing. Its NAICS code is 31122 and its SIC code is 2000.